Mezlocillinum
Mezlocillinum Uses, Dosage, Side Effects, Food Interaction and all others data.
Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.
Mezlocillinum is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Mezlocillinum has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of mezlocillin results from the inhibition of cell wall synthesis and is mediated through mezlocillin binding to penicillin binding proteins (PBPs). Mezlocillinum is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Mezlocillinum can be used to treat susceptible strains of H. influenzae, Klebsiella species, Pseudomonas species, Proteus mirabilis, E. coli, Enterobacter species, Streptococcus faecelis, Peptococcus species, Peptostreptococcus species, Bacteriodes species (including B. fragilis), Morganella morganii, Serratia species, N. gonorrhoeae, P. vulgaris, and Providencia rettgeri. This drug is discontinued in the U.S.
Trade Name | Mezlocillinum |
Availability | Discontinued |
Generic | Mezlocillin |
Mezlocillin Other Names | Mezlocilina, Mezlocillin, Mezlocilline, Mezlocillinum |
Related Drugs | amoxicillin, doxycycline, ciprofloxacin, metronidazole, azithromycin, clindamycin, ceftriaxone, levofloxacin, Augmentin, vancomycin |
Type | |
Formula | C21H25N5O8S2 |
Weight | Average: 539.582 Monoisotopic: 539.114454181 |
Protein binding | 16-59% |
Groups | Approved, Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Used to treat serious gram–negative infections of the lungs, urinary tract, and skin.
How Mezlocillinum works
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, mezlocillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that mezlocillin interferes with an autolysin inhibitor.
Toxicity
Symptoms of overdose include rash, fever, chills, and peeling skin.
Mezlocillinum Hypertension interaction
[Moderate] Parenteral mezlocillin sodium contains approximately 43 mg (1.85 mEq) of sodium per each gram of mezlocillin activity.
The sodium content should be considered in patients with conditions that may require sodium restriction, such as congestive heart failure, hypertension, and fluid retention.
In addition, hypokalemia has been reported rarely during therapy with mezlocillin and other extended-spectrum penicillin antibiotics, which may be particularly important to bear in mind when treating patients with low potassium reserves or fluid and electrolyte imbalance.
Clinical monitoring of electrolytes is recommended if these agents are used for prolonged periods.
Mezlocillinum Disease Interaction
Major: colitisModerate: coagulation abnormalities, renal dysfunction, sodium/potassium, hemodialysis
Half Life
1.3 to 4.4 hours
Innovators Monograph
You find simplified version here Mezlocillinum